569
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Validation of ulcerative colitis and Crohn’s disease and their phenotypes in the Danish National Patient Registry using a population-based cohort

, , & ORCID Icon
Pages 1171-1175 | Received 01 Jul 2020, Accepted 04 Aug 2020, Published online: 24 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Saeed Shakibfar, Kristine H Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven & Maurizio Sessa. (2024) Drug Repurposing in Crohn’s Disease Using Danish Real-World Data. Pragmatic and Observational Research 15, pages 17-29.
Read now
Kristoffer Jarlov Jensen, Camilla Bjørn Jensen, Christina Wennerström, Johan Burisch & Janne Petersen. (2023) Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: a population-based Danish cohort study 2015–2020. Scandinavian Journal of Gastroenterology 58:7, pages 726-736.
Read now
Navkiran T. Tornkvist, Ann-Sofie Backman, Marie Linder, Maria Altman, Magnus Simrén, Ola Olén & Hans Törnblom. (2023) Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study. Scandinavian Journal of Gastroenterology 58:7, pages 709-717.
Read now
Natalia Mouratidou, Petter Malmborg, Jacob Järås, Vignir Sigurdsson, Olof Sandström, Ulrika L Fagerberg, Gabriella Bröms, Jonas F Ludvigsson & Ola Olén. (2022) Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study. Clinical Epidemiology 14, pages 591-600.
Read now
Karoline Anisdahl, Sandre Svatun Lirhus, Asle W. Medhus, Bjørn Moum, Hans Olav Melberg & Marte Lie Høivik. (2021) First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study. Scandinavian Journal of Gastroenterology 56:10, pages 1163-1168.
Read now

Articles from other publishers (20)

Guoli Sun, Emil L Fosbøl, Morten Schou, Mikkel Faurschou, Adelina Yafasova, Jeppe K Petersen, Ketil J Haugan, Ulrik Madvig Mogensen, Jesper H Svendsen, Lars Køber & Jawad H Butt. (2024) Long-term rate of ventricular arrhythmia in autoimmune disease. European Journal of Preventive Cardiology.
Crossref
Karoline Anisdahl, Sandre Svatun Lirhus, Asle W Medhus, Bjørn Moum, Hans Olav Melberg & Marte Lie Høivik. (2024) Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study. Digestive and Liver Disease.
Crossref
Bobby Lo, Luc Biederman, Gerhard Rogler, Barbara Dora, Andrea Kreienbühl, Ida Vind, Flemming Bendtsen & Johan Burisch. (2024) Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study. Journal of Crohn's and Colitis.
Crossref
Linéa Bonfils, Anastasia Karachalia SandriGry J. PoulsenManasi AgrawalDaniel J. Ward, Jean-Frederic ColombelTine JessKristine H. Allin. (2023) Medication-Wide Study: Exploring Medication Use 10 Years Before a Diagnosis of Inflammatory Bowel Disease. American Journal of Gastroenterology 118:12, pages 2220-2229.
Crossref
Sabine Jansson, Mikkel Malham, Katrine Carlsen, Helene Ingels, Marianne Hørby Jørgensen, Lauri Juhani Virta, Kaija-Leena Kolho, Charlotte Ulrikka Rask & Vibeke Wewer. (2023) Psychiatric disorders in paediatric-onset immune-mediated inflammatory diseases: a nationwide Danish study. Archives of Disease in Childhood 108:12, pages 999-1007.
Crossref
Joe West, Peter Jepsen, Timothy R. Card, Colin J. Crooks & Mark Bishton. (2023) Incidence and Survival in Patients With Enteropathy-associated T-Cell Lymphoma: Nationwide Registry Studies From England and Denmark. Gastroenterology 165:4, pages 1064-1066.e3.
Crossref
Guoli Sun, Mikkel Faurschou, Naja E Vinding, Adelina Yafasova, Søren L Kristensen, Ole Ahlehoff, Morten Schou, Emil L Fosbøl, Lars Køber & Jawad H Butt. (2023) Mortality in heart failure with and without autoimmune disease. European Journal of Preventive Cardiology 30:13, pages 1308-1314.
Crossref
Shahed Kamal, Nikita Parkash, William Beattie, Britt Christensen & Jonathan P. Segal. (2023) Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?. Journal of Clinical Medicine 12:18, pages 5786.
Crossref
M.Z. Sarikaya, M. Zhao, B. Lo, F. Bendtsen & J. Burisch. (2023) Disease course and treatment outcomes of Crohn's disease patients with early or late surgery – A Danish nationwide cohort study from 1997 to 2015. Digestive and Liver Disease 55:7, pages 872-879.
Crossref
Guoli Sun, Emil L. Fosbøl, Adelina Yafasova, Mikkel Faurschou, Jesper Lindhardsen, Christian Torp‐Pedersen, Lars Køber & Jawad H. Butt. (2022) Long‐term risk of heart failure and other adverse cardiovascular outcomes in primary Sjögren's syndrome. Journal of Internal Medicine 293:4, pages 457-469.
Crossref
Joana Torres, Catarina Gomes, Camilla B Jensen, Manasi Agrawal, Francisco Ribeiro-Mourão, Tine Jess, Jean-Frédéric Colombel, Kristine H Allin & Johan Burisch. (2023) Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD. Journal of Crohn's and Colitis 17:1, pages 30-36.
Crossref
Manasi Agrawal, Kristine H. Allin, Aske T. Iversen, Saurabh Mehandru, Jean-Frederic Colombel & Tine Jess. (2022) Early-Life Mebendazole Exposure Increases the Risk of Adult-Onset Ulcerative Colitis: A Population-Based Cohort Study. American Journal of Gastroenterology 117:12, pages 2025-2032.
Crossref
Bobby Lo, ZhuoYuan Liu, Flemming Bendtsen, Christian Igel, Ida Vind & Johan Burisch. (2022) High Accuracy in Classifying Endoscopic Severity in Ulcerative Colitis Using Convolutional Neural Network. American Journal of Gastroenterology 117:10, pages 1648-1654.
Crossref
Kristine H. Allin, Camilla B. Jensen, Rikke K. Jacobsen & Tine Jess. (2022) Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study. Journal of Gastroenterology 57:10, pages 761-769.
Crossref
Mirabella Zhao, Sandre Lirhus, Mikael Lördal, Ebbe Langholz, Torben Knudsen, Markku Voutilainen, Marte Lie Høivik, Bjorn Moum, Karoline Anisdahl, Borghild Sæbø, Paula Haiko, Carolina Malmgren, Mehmet Coskun, Hans Olav Melberg & Johan Burisch. (2022) Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway. Alimentary Pharmacology & Therapeutics 56:6, pages 989-1006.
Crossref
David Thein, Alexander Egeberg, Lone Skov & Nikolai Loft. (2022) Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases. JAMA Dermatology 158:9, pages 997.
Crossref
Nathalie Fogh Rasmussen, Anders Green, Kristine Højgaard Allin, Aske T Iversen, Gunvor Iben Madsen, Andreas Kristian Pedersen, Donna Lykke Wolff, Tine Jess & Vibeke Andersen. (2022) Clinical procedures used to diagnose inflammatory bowel disease: real-world evidence from a Danish nationwide population-based study. BMJ Open Gastroenterology 9:1, pages e000958.
Crossref
Mirabella Zhao, Morten Sall Jensen, Torben Knudsen, Jens Kelsen, Mehmet Coskun, Jakob Kjellberg & Johan Burisch. (2021) Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases – a Danish nationwide cohort study. Alimentary Pharmacology & Therapeutics 55:5, pages 541-557.
Crossref
Kristine H. Allin, Manasi Agrawal, Aske T. Iversen, Jacob Antonsen, Marie Villumsen & Tine Jess. (2022) The Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease After Bowel Resections: A Nationwide Cohort Study. Gastro Hep Advances 1:5, pages 777-784.
Crossref
Charlotte Hyldgaard, Elisabeth Bendstrup, Alma Becic Pedersen, Lars Pedersen & Torkell Ellingsen. (2021) Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort. Journal of Clinical Medicine 10:21, pages 4830.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.